Serum S-100B Protein as A Biochemical Marker of Brain Injury: A Review of Current Concepts

E-ISSN： 1875-533x|13|30|3719-3731

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.30, 2006-01, pp. : 3719-3731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Biochemical Markers of Brain Injury

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 2, 2009-02 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Protein S-100B - A Prognostic Marker for Cerebral Damage

Current Medicinal Chemistry, Vol. 13, Iss. 25, 2006-10 ,pp. : 3053-3060

Bentham Science Publishers

Access to resources Recommend Favorite

Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases

Current Medicinal Chemistry, Vol. 23, Iss. 15, 2016-05 ,pp. : 1571-1596

Bentham Science Publishers

Access to resources Recommend Favorite

Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study

By Machado-Vieira R. Lara D.R. Portela L.V.C. Goncalves C.A. Soares J.C. Kapczinski F. Souza D.O.

European Neuropsychopharmacology, Vol. 12, Iss. 3, 2002-06 ,pp. : 269-272

Elsevier

Access to resources Recommend Favorite

Evaluation of a 4-protein serum biomarker panel—biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)—for the detection of esophageal adenocarcinoma

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3902-3913

Blackwell Publishing

Access to resources Recommend Favorite